The Amgen pharmaceutical of The United States invested two hundred million to build a new plant in Singapore, It is reported that the new plant will be located in Singapore Tuas Biomedical Park.

The Amgen pharmaceutical company said that they will start the construction as soon as possible, the production plant is mainly used for increasing Amgen pharmaceutical company in monoclonal antibody production. According to the chief of Amgen pharmaceutical company, that one of the company's global expansion plan was to build a new factory in Singapore.

After the completion of the new plant, Amgen pharmaceutical company will recruit some experienced staffs, the new factory mainly produces all kinds of clinical and commercial drugs.